216 related articles for article (PubMed ID: 27866836)
1. Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP.
Papazyan R; Sun Z; Kim YH; Titchenell PM; Hill DA; Lu W; Damle M; Wan M; Zhang Y; Briggs ER; Rabinowitz JD; Lazar MA
Cell Metab; 2016 Dec; 24(6):863-874. PubMed ID: 27866836
[TBL] [Abstract][Full Text] [Related]
2. Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass.
Knebel B; Haas J; Hartwig S; Jacob S; Köllmer C; Nitzgen U; Muller-Wieland D; Kotzka J
PLoS One; 2012; 7(2):e31812. PubMed ID: 22363740
[TBL] [Abstract][Full Text] [Related]
3. The role of KLF2 in regulating hepatic lipogenesis and blood cholesterol homeostasis via the SCAP/SREBP pathway.
Huang Y; Wang YF; Ruan XZ; Lau CW; Wang L; Huang Y
J Lipid Res; 2024 Jan; 65(1):100472. PubMed ID: 37949368
[TBL] [Abstract][Full Text] [Related]
4. Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes.
Yin HQ; Kim YC; Chung YS; Kim YC; Shin YK; Lee BH
Toxicol Appl Pharmacol; 2009 Apr; 236(1):124-30. PubMed ID: 19371623
[TBL] [Abstract][Full Text] [Related]
5. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW
Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089
[TBL] [Abstract][Full Text] [Related]
6. Low abundance of insulin-induced gene 1 contributes to SREBP-1c processing and hepatic steatosis in dairy cows with severe fatty liver.
Zhu Y; Lei L; Wang X; Jiang Q; Loor JJ; Kong F; Chen L; Li J; Zhao C; Liu M; Liu G; Li X
J Dairy Sci; 2023 Aug; 106(8):5626-5635. PubMed ID: 37291038
[TBL] [Abstract][Full Text] [Related]
7. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model.
Ji C; Chan C; Kaplowitz N
J Hepatol; 2006 Nov; 45(5):717-24. PubMed ID: 16879892
[TBL] [Abstract][Full Text] [Related]
8. The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis.
Chandrasekaran P; Weiskirchen R
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256181
[TBL] [Abstract][Full Text] [Related]
9. Brg1 regulates pro-lipogenic transcription by modulating SREBP activity in hepatocytes.
Li N; Li M; Hong W; Shao J; Xu H; Shimano H; Lu J; Xu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2881-2889. PubMed ID: 29857051
[TBL] [Abstract][Full Text] [Related]
10. Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome.
Libby AE; Bales E; Orlicky DJ; McManaman JL
J Biol Chem; 2016 Nov; 291(46):24231-24246. PubMed ID: 27679530
[TBL] [Abstract][Full Text] [Related]
11. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
12. E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis.
Tong X; Li P; Zhang D; VanDommelen K; Gupta N; Rui L; Omary MB; Yin L
J Lipid Res; 2016 Jul; 57(7):1219-30. PubMed ID: 27252523
[TBL] [Abstract][Full Text] [Related]
13. Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype.
Shen L; Cui A; Xue Y; Cui Y; Dong X; Gao Y; Yang H; Fang F; Chang Y
J Biol Chem; 2014 Aug; 289(34):23332-42. PubMed ID: 24993831
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice.
Zhang C; Wang G; Zheng Z; Maddipati KR; Zhang X; Dyson G; Williams P; Duncan SA; Kaufman RJ; Zhang K
Hepatology; 2012 Apr; 55(4):1070-82. PubMed ID: 22095841
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
Wu J; Wang C; Li S; Li S; Wang W; Li J; Chi Y; Yang H; Kong X; Zhou Y; Dong C; Wang F; Xu G; Yang J; Gustafsson JÅ; Guan Y
Hepatology; 2013 Aug; 58(2):617-28. PubMed ID: 23348573
[TBL] [Abstract][Full Text] [Related]
16. Smurf1 aggravates non-alcoholic fatty liver disease by stabilizing SREBP-1c in an E3 activity-independent manner.
Zhang X; Zhan Y; Lin W; Zhao F; Guo C; Chen Y; Du M; Li D; Zhang L; An W; Wang HR; Xie P
FASEB J; 2020 Jun; 34(6):7631-7643. PubMed ID: 32301540
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis.
Massart J; Robin MA; Noury F; Fautrel A; Lettéron P; Bado A; Eliat PA; Fromenty B
Br J Pharmacol; 2012 Mar; 165(5):1361-74. PubMed ID: 21740407
[TBL] [Abstract][Full Text] [Related]
18. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP).
You M; Fischer M; Deeg MA; Crabb DW
J Biol Chem; 2002 Aug; 277(32):29342-7. PubMed ID: 12036955
[TBL] [Abstract][Full Text] [Related]
19. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
Xu L; Kim JK; Bai Q; Zhang X; Kakiyama G; Min HK; Sanyal AJ; Pandak WM; Ren S
Mol Pharmacol; 2013 Mar; 83(3):648-58. PubMed ID: 23258548
[TBL] [Abstract][Full Text] [Related]
20. HDAC5 Inhibits Hepatic Lipogenic Genes Expression by Attenuating the Transcriptional Activity of Liver X Receptor.
Jia HY; Li QZ; Lv LF
Cell Physiol Biochem; 2016; 39(4):1561-7. PubMed ID: 27614433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
